Thursday, October 25, 2007 7:25:11 PM
Thu Oct 25, 2007 5:13pm EDT
Email | Print | Digg | Reprints | Single Page | Recommend (-)
[-] Text [+]
Market News
Microsoft lifts profit outlook, shares rise | Video
Wall Street hit by write-downs, earnings
AIG stock falls on fear over possible write-down
More Business & Investing News...
WASHINGTON, Oct 25 (Reuters) - Avalon Pharmaceuticals Inc (AVRX.O: Quote, Profile, Research) filed with regulators on Thursday to periodically sell up to $50 million in common and preferred stock, debt securities and warrants.
The company said in a registration statement with the U.S. Securities and Exchange Commission that it will use the proceeds from the offering for clinical drug development, discovery of new drug candidates, the protection of intellectual property rights, and other purposes.
Under a shelf registration, a company may sell securities in one or more separate offerings with the size, price and terms to be determined at the time of sale.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM